The Investigational Drug

For the PROSEEK study, the investigational drug is being studied to see if it can slow the progression of Parkinson's disease. It is designed to block a specific enzyme called “Abl” (an enzyme is a biological molecule that accelerates certain chemical reactions in the body). Research has shown that overactivation of Abl may play a role in the progression of Parkinson’s disease. Therefore, by limiting or blocking Abl, it may be possible to help slow the progression of PD.

See if you may prequalify click above or call us at +1 518‑650‑3956